Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Apr-23 4:51 PM View:  | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 10-Apr-23 | Sale | 16,544,100 | $0.12 | $1,985,290.00 | (99%) 16.74M to 200.0K | |
| 17-Feb-23 4:09 PM View: | Bauerlein Alison Director | Pear Therapeutics, Inc. (PEAR) | 15-Feb-23 | Grant | 71,428 | -- | -- | 100% 0 to 71.43K | |
| 17-Feb-23 4:11 PM View: | Reddy Kirthiga Director | Pear Therapeutics, Inc. (PEAR) | 15-Feb-23 | Grant | 61,904 | -- | -- | 100% 0 to 61.9K | |
| 17-Feb-23 4:10 PM View: | Mango Paul Director | Pear Therapeutics, Inc. (PEAR) | 15-Feb-23 | Grant | 52,380 | -- | -- | 100% 0 to 52.38K | |
| 17-Feb-23 4:11 PM View: | Schlichting Nancy M Director | Pear Therapeutics, Inc. (PEAR) | 15-Feb-23 | Grant | 66,666 | -- | -- | 100% 0 to 66.67K | |
| 17-Feb-23 4:10 PM View: | Rajaraman Shivakumar Director | Pear Therapeutics, Inc. (PEAR) | 15-Feb-23 | Grant | 52,380 | -- | -- | 100% 0 to 52.38K | |
| 17-Feb-23 4:12 PM View: | Wicks Timothy A Director | Pear Therapeutics, Inc. (PEAR) | 15-Feb-23 | Grant | 52,380 | -- | -- | 100% 0 to 52.38K | |
| 24-Jan-23 4:07 PM View: | Jeffery Katherine Chief People Officer | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 7,096 | $1.13 | $8,018.48 | (46%) 15.4K to 8.3K | |
| 24-Jan-23 4:08 PM View: | Strandberg Julia Chief Commercial Officer | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 12,688 | $1.13 | $14,337.40 | (31%) 41.3K to 28.61K | |
| 24-Jan-23 4:06 PM View: | McCann Corey President and CEO Director | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 34,731 | $1.13 | $39,246.00 | (< 1%) 10.92M to 10.88M | |
| 24-Jan-23 4:07 PM View: | Guiffre Christopherd T CFO, COO, Treas., & Asst. Sec. | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 19,540 | $1.13 | $22,080.20 | (39%) 49.5K to 29.96K | |
| 24-Jan-23 4:08 PM View: | Snow Ellen Chief Accounting Officer | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 8,027 | $1.13 | $9,070.51 | (26%) 31.34K to 23.32K | |
| 24-Jan-23 4:07 PM View: | Maricich Yuri Chief Medical Officer | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 12,162 | $1.13 | $13,743.10 | (11%) 106.5K to 94.33K | |
| 24-Jan-23 4:08 PM View: | Brenner Erin K. Chief Product Dev. Officer | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 8,690 | $1.13 | $9,819.70 | (17%) 52.0K to 43.31K | |
| 24-Jan-23 4:08 PM View: | O'Brien Ronan GC, CCO & Secretary | Pear Therapeutics, Inc. (PEAR) | 20-Jan-23 | Sale | 12,162 | $1.13 | $13,743.10 | (39%) 30.8K to 18.64K | |
| 18-Jan-23 5:01 PM View: | O'Brien Ronan GC, CCO & Secretary | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 30,800 | -- | -- | 100% 0 to 30.8K | |
| 18-Jan-23 5:03 PM View: | Guiffre Christopherd T CFO, COO, Treas., & Asst. Sec. | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 49,500 | -- | -- | 100% 0 to 49.5K | |
| 18-Jan-23 6:42 PM View: | Brenner Erin K. Chief Product Dev. Officer | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 22,000 | -- | -- | 73% 30.0K to 52.0K | |
| 18-Jan-23 5:01 PM View: | Strandberg Julia Chief Commercial Officer | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 33,000 | -- | -- | 398% 8.3K to 41.3K | |
| 18-Jan-23 5:03 PM View: | McCann Corey President and CEO Director | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 88,000 | -- | -- | < 1% 10.83M to 10.92M | |
| 18-Jan-23 5:01 PM View: | Jeffery Katherine Chief People Officer | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 15,400 | -- | -- | 100% 0 to 15.4K | |
| 18-Jan-23 5:02 PM View: | Snow Ellen Chief Accounting Officer | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 20,320 | -- | -- | 184% 11.03K to 31.34K | |
| 18-Jan-23 5:05 PM View: | Maricich Yuri Chief Medical Officer | Pear Therapeutics, Inc. (PEAR) | 14-Jan-23 | Option Exercise | 30,800 | -- | -- | 41% 75.69K to 106.5K | |
| 13-Dec-22 6:00 PM View: | Lj10 LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 09-Dec-22 | Disposition (other) | 430,000 | -- | -- | (3%) 12.93M to 12.5M | |
| 09-Dec-22 5:02 PM View: | Brenner Erin K. Chief Product Dev. Officer | Pear Therapeutics, Inc. (PEAR) | 09-Dec-22 | Option Exercise | 15,000 | $1.00 | $15,000.00 | 100% 15.0K to 30.0K | |
| 15-Nov-22 8:32 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 15-Nov-22 | Sale | 63,773 | $2.52 | $160,708.00 | (< 1%) 16.81M to 16.74M | |
| 15-Nov-22 8:32 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 14-Nov-22 | Sale | 12,128 | $2.79 | $33,837.10 | (< 1%) 16.82M to 16.81M | |
| 15-Nov-22 8:32 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 11-Nov-22 | Sale | 29,380 | $3.19 | $93,722.20 | (< 1%) 16.85M to 16.82M | |
| 02-Nov-22 7:49 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 02-Nov-22 | Sale | 10,578 | $2.72 | $28,772.20 | (< 1%) 30.35M to 30.34M | |
| 02-Nov-22 7:49 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 01-Nov-22 | Sale | 1,467 | $2.80 | $4,107.60 | (< 1%) 30.35M to 30.35M | |
| 02-Nov-22 7:49 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 31-Oct-22 | Sale | 42,164 | $2.78 | $117,216.00 | (< 1%) 30.39M to 30.35M | |
| 16-Sep-22 6:03 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 16-Sep-22 | Sale | 351 | $1.75 | $614.25 | (< 1%) 30.44M to 30.43M | |
| 16-Sep-22 6:03 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 15-Sep-22 | Sale | 272,750 | $1.81 | $493,678.00 | (< 1%) 30.71M to 30.44M | |
| 16-Sep-22 6:03 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 14-Sep-22 | Sale | 285,067 | $1.94 | $553,030.00 | (< 1%) 30.99M to 30.71M | |
| 08-Sep-22 8:01 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 08-Sep-22 | Sale | 304,322 | $1.81 | $550,823.00 | (< 1%) 32.16M to 31.86M | |
| 08-Sep-22 8:01 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 07-Sep-22 | Sale | 154,518 | $1.92 | $296,675.00 | (< 1%) 32.31M to 32.16M | |
| 08-Sep-22 8:01 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 06-Sep-22 | Sale | 311,160 | $2.36 | $734,338.00 | (< 1%) 32.63M to 32.31M | |
| 18-Aug-22 8:05 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 18-Aug-22 | Sale | 222,761 | $1.55 | $345,280.00 | (< 1%) 33.54M to 33.31M | |
| 18-Aug-22 8:05 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 17-Aug-22 | Sale | 10,077 | $1.71 | $17,231.70 | (< 1%) 33.55M to 33.54M | |
| 18-Aug-22 8:05 PM View: | 5am Partners Iv, LLC 10% Owner | Pear Therapeutics, Inc. (PEAR) | 16-Aug-22 | Sale | 167,162 | $1.78 | $297,548.00 | (< 1%) 33.71M to 33.55M | |
| 27-May-22 4:02 PM View: | Brenner Erin K. Chief Product Dev. Officer | Pear Therapeutics, Inc. (PEAR) | 25-May-22 | Option Exercise | 15,000 | $1.00 | $15,000.00 | 100% 0 to 15.0K | |
| 07-Dec-21 5:23 PM View: | McCann Corey President and CEO Director | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Grant | 2,672,430 | -- | -- | 33% 8.16M to 10.83M | |
| 06-Dec-21 8:30 PM View: | Lj10 LLC | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Conversion | 6,540,000 | -- | -- | 100% 0 to 6.54M | |
| 07-Dec-21 5:23 PM View: | Maricich Yuri Chief Medical Officer | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Grant | 73,620 | -- | -- | 100% 0 to 73.62K | |
| 07-Dec-21 5:23 PM View: | Lynch Zack Director | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Grant | 10,766,600 | $0.01 | $100,000.00 | 100% 0 to 10.77M | |
| 07-Dec-21 5:23 PM View: | McCann Corey President and CEO Director | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Grant | 8,157,660 | -- | -- | 100% 0 to 8.16M | |
| 07-Dec-21 5:25 PM View: | Schwab Andrew J. Director 10% Owner | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Grant | 18,631,800 | $0.11 | $2,000,000.00 | 100% 0 to 18.63M |
